SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-046931
Filing Date
2024-04-23
Accepted
2024-04-23 16:25:42
Documents
5
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A srzn_2024_def_14a.htm DEF 14A 871787
2 GRAPHIC img171194897_0.jpg GRAPHIC 40351
3 GRAPHIC img171194897_1.jpg GRAPHIC 26583
4 GRAPHIC img171194897_2.jpg GRAPHIC 121268
5 GRAPHIC img171194897_3.jpg GRAPHIC 152982
  Complete submission text file 0000950170-24-046931.txt   1343144
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39635 | Film No.: 24865142
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)